High statistical heterogeneity is more frequent in meta-analysis of continuous than binary outcomes.

[1]  W. McGuire,et al.  Glutamine supplementation to prevent morbidity and mortality in preterm infants. , 2016, The Cochrane database of systematic reviews.

[2]  S. Fisher,et al.  Stem cell treatment for acute myocardial infarction. , 2015, The Cochrane database of systematic reviews.

[3]  Paul Garner,et al.  Deworming drugs for soil‐transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin, and school performance , 2015, The Cochrane database of systematic reviews.

[4]  Levente Kriston,et al.  Dealing with clinical heterogeneity in meta‐analysis. Assumptions, methods, interpretation , 2013, International journal of methods in psychiatric research.

[5]  G. Guyatt,et al.  Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials , 2012, Canadian Medical Association Journal.

[6]  C. Reimer,et al.  Fermented milk for hypertension. , 2012, The Cochrane database of systematic reviews.

[7]  N. Tabet,et al.  Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease. , 2012, The Cochrane database of systematic reviews.

[8]  Gerald Gartlehner,et al.  [GRADE guidelines: 7. Rating the quality of evidence - inconsistency]. , 2012, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[9]  A. Bhandari,et al.  Positioning for acute respiratory distress in hospitalised infants and children. , 2012, The Cochrane database of systematic reviews.

[10]  D. Taylor-Robinson,et al.  Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin and school performance. , 2012, The Cochrane database of systematic reviews.

[11]  M. Coory,et al.  Comment on: Heterogeneity in meta-analysis should be expected and appropriately quantified. , 2010, International journal of epidemiology.

[12]  M. Brady,et al.  Speech and language therapy for aphasia following stroke. , 2010, The Cochrane database of systematic reviews.

[13]  D. Bennett,et al.  Stratification for exploring heterogeneity in systematic reviews , 2009, Annals of Internal Medicine.

[14]  Gerta Rücker,et al.  Undue reliance on I2 in assessing heterogeneity may mislead , 2008, BMC medical research methodology.

[15]  Julian P T Higgins,et al.  Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. , 2008, International journal of epidemiology.

[16]  Gordon H Guyatt,et al.  GrADe : what is “ quality of evidence ” and why is it important to clinicians ? rATING quALITY of evIDeNCe AND STreNGTH of reCommeNDATIoNS , 2022 .

[17]  J. Sterne,et al.  Meta‒Analysis in Stata™ , 2008 .

[18]  S. Brunskill,et al.  Stem cell treatment for acute myocardial infarction. , 2008, The Cochrane database of systematic reviews.

[19]  Tania B. Huedo-Medina,et al.  Assessing heterogeneity in meta-analysis: Q statistic or I2 index? , 2006, Psychological methods.

[20]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[21]  Fujian Song,et al.  Quality of Cochrane reviews , 2002, BMJ : British Medical Journal.

[22]  F. Ducharme,et al.  Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. , 2002, The Cochrane database of systematic reviews.

[23]  Douglas G. Altman,et al.  Systematic reviews in health care : meta-analysis in context , 2008 .

[24]  J. Ioannidis,et al.  Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.